Abiopharma

Calidi Biotherapeutics - Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026

Dario Demonstrates Improved Workplace Function and Productivity Outcomes Through Digital Behavioral Health Program: Real-World Study Published in JMIR Formative Research

Safe Pro Reports on Share Repurchase Program, Reinforcing Commitment to Shareholder Value and Capital Return

Amneal Pharmaceuticals, Inc. - Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results withCREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching fromRYTARY®

Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026

POSaBIT to Host Fourth Quarter and FY 2025 Earnings Conference Call

COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations

Fiserv to Release First Quarter Earnings Results on May 5, 2026 and Confirms Details for May 14, 2026 Investor Day

McKesson Corporation - McKesson Signs Agreement with Apollo Funds for Strategic Minority Interest in Medical-Surgical Solutions

MaxsMaking Inc. Commences U.S. Business Operations